How benzodiazepines addiction treatment works

Effective benzodiazepines treatment follows the ASAM continuum of care — a six-dimension clinical assessment that matches treatment intensity to individual need. The framework (developed by the American Society of Addiction Medicine) is used by virtually every licensed addiction program in the US and is recognised by Medicare, Medicaid, and every major commercial insurer.

Three clinical questions determine placement. First, withdrawal severity: can you safely stop for 24 hours without medical help? For benzodiazepines, if daily use has continued for 30+ days, medical detox is almost always indicated first — particularly because unsupervised withdrawal from alcohol, benzodiazepines, and opioids can be dangerous. Second, home-environment stability: is home a supportive recovery space or a triggering one? Unstable home typically means residential; stable means outpatient or IOP. Third, co-occurring conditions: untreated depression, PTSD, or anxiety doubles relapse risk — these need integrated dual-diagnosis programs.

FDA-approved medications and evidence-based therapy

Modern treatment pairs clinical therapy (CBT, motivational interviewing, contingency management) with FDA-approved MAT medications where available. For benzodiazepines, the evidence base varies — some substances have multiple FDA-approved medications, others rely on behavioral therapy as first-line treatment. Regardless of substance, 90+ days of engaged treatment plus structured aftercare (sober living, peer support via 12-step or SMART Recovery) is the single strongest predictor of long-term success.

For cost specifics, residential treatment runs $5,000–$20,000 for 30 days without insurance, $12,000–$60,000 for 90 days. With Aetna, BCBS, Cigna, UnitedHealthcare, or Medicaid, out-of-pocket typically drops to $500–$8,000 after deductible. Outpatient care is even less — usually a $20–$50 copay per session. Call (833) 567-5838 for a free benefits check specific to your plan.